Lucus Advisors’s AngioDynamics ANGO Stock Holding History

Lucus Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-20,036	Closed	-$333K	–	198
2017 Q4	$333K	Buy	20,036 +786	+4%	+$13.4K	0.49%	101
2017 Q3	$329K	Buy	+19,250	New	+$323K	0.46%	181

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Lucus Advisors's ANGO Position: Q1 2018 in Review

Lucus Advisors sold out of AngioDynamics (ANGO) in Q1 2018, closing a stake of 20,036 shares — an estimated $333K sold.

Lucus Advisors first reported a position in ANGO in Q3 2017 and held it in 2 quarters. The position peaked at $333K in Q4 2017. 164 funds tracked by Wall St. Rank hold ANGO as of Q1 2018.

Lucus Advisors reported no remaining AngioDynamics position as of Q1 2018 after selling out during the quarter.
Lucus Advisors sold 20,036 AngioDynamics shares in Q1 2018, an estimated $333K.
Lucus Advisors first reported a position in AngioDynamics in Q3 2017 and held it in 2 quarters.
Lucus Advisors's AngioDynamics position peaked at $333K in Q4 2017.
164 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2018.

Based on Lucus Advisors's 13F filing for Q1 2018, filed 15 May 2018.